NEUROCRINE BIOSCIENCES INC
SEC CIK 914475 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | 10% | 8.58M | $39.03M | — | 1 | 2023-02-23 | 2023-02-23 |
Most active insiders at VYGR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sandrock Alfred | Pres, CEO, Dir | — | $184.4K |
| 2 | Swartz Robin | COO, CBO | — | $55.3K |
| 3 | Jorgensen Nathan D. | CFO | — | $54.2K |
| 4 | Carter Todd Alfred | CSO | — | $40.6K |
| 5 | Shiferman Gregory L. | SVP, GC | — | — |
| 6 | Ferguson Toby | Chief Medical Off | — | — |
NEUROCRINE BIOSCIENCES INC made no open-market trades at VYGR in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-24 | 2023-02-23 | VYGR | Voyager Therapeutics, Inc. | NEUROCRINE BIOSCIENCES INC | 10% | P - Purchase | $8.88 | +4.40M | 8.58M | +105% | +$39.03M |
Purchase Sale Sale after option exercise All abbreviations